Graph AI

Graph AI was founded in 2024 with the aim of transforming pharmacovigilance by addressing inefficiencies in traditional drug safety monitoring. Its flagship platform, Graph Safety, automates key processes such as adverse event case handling, signal detection, and regulatory reporting, significantly improving efficiency and reducing costs for enterprise customers.